Ads
related to: treatment options for huntington's disease- A Treatment Option
Learn About A Treatment
Option For HD Chorea.
- Common Side Effects
Learn About The Side Effects Of HD
Chorea Medication On Patients.
- Financial Assistance Info
Find Answers To Treatment
Free 30-day Trial Offer.
- Understanding HD
Chorea Is The Most Visible Symptom
Of HD. Learn More About Symptoms.
- Register Today
Register To Receive Updates And
Resources About HD Chorea.
- Living With HD Chorea?
View Tips On Building A Healthcare
Support Network For Your HD Chorea.
- A Treatment Option
Search results
Results From The WOW.Com Content Network
Huntington's disease (HD), also known as Huntington's chorea, is an incurable neurodegenerative disease [7] that is mostly inherited. [8] The earliest symptoms are often subtle problems with mood or mental/psychiatric abilities. [9] [1] A general lack of coordination and an unsteady gait often follow. [2]
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders.It is sold under the brand names Nitoman and Xenazine among others. On August 15, 2008, the U.S. Food and Drug Administration approved the use of tetrabenazine to treat chorea associated with Huntington's disease.
His scientific interest is dementia, especially Huntington's disease. [2] [3] With his neuropsychiatric research group he described eight new treatment options for this disease: Pramipexol, [4] Quetiapine, [5] Minocycline, [6] [7] Mirtazapine, [8] Zotepine, [9] Ziprasidone, [10] Venlafaxine [11] and antipsychotic drug holidays in Huntington's ...
Branaplam (development codes LMI070 and NVS-SM1) is a pyridazine derivative that is being studied as an experimental drug.It was originally developed by Novartis to treat spinal muscular atrophy (SMA); since 2020 it was being developed to treat Huntington's disease but the trial ended in 2023 due to toxicity concerns.
Neurodegenerative diseases include amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple system atrophy, tauopathies, and prion diseases. Neurodegeneration can be found in the brain at many different levels of neuronal circuitry, ranging from molecular to systemic. [4]
AB-1001 is an experimental gene therapy developed for Huntington's disease. It is intended to increase the production of the CYP46A1 enzyme and cholesterol levels in the brain. [ 1 ] [ 2 ]
Ads
related to: treatment options for huntington's disease